Wenjiao Tang

5PUBLICATIONS
20CO-AUTHORS
Medical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 05, 2025
Incidence, Clinical Features, and Prognostic Value of New-Onset Renal Impairment in Multiple Myeloma.

Xiang Liu, Qian Hu, Yuhuan Zheng

|Oct 10, 2025
Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.

Hongbin Yu, Tian Chen, Xin Zhang

|Aug 27, 2025
Navigating the Prognostic Complexity of IgH Cytogenetic Abnormalities in Multiple Myeloma Among Diverse IgH Cytogenetic Abnormalities-Involved High-Risk Stratifications.

Yanqiu Xiong, Meng Li, Yan Li

|Feb 18, 2025
Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis.

Hexiang Bai, Chunlan Zhang, Ailin Zhao

|Jul 20, 2024
Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma.

Wenjiao Tang, Yan Li, Li Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Li Zhang

2 joint publications

Yuhuan Zheng

2 joint publications

Ting Niu

1 joint publications

Yun Zeng